Get the Stockscreener App
0.8133
2.19%
0.0174
After Hours:
.82
0.0067
+0.82%
Hyperfine Inc stock is traded at $0.8133, with a volume of 246.84K.
It is up +2.19% in the last 24 hours and down -6.50% over the past month.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
See More
Previous Close:
$0.7959
Open:
$0.8
24h Volume:
246.84K
Relative Volume:
0.29
Market Cap:
$86.25M
Revenue:
$15.33M
Net Income/Loss:
$-34.78M
P/E Ratio:
-1.99
EPS:
-0.4087
Net Cash Flow:
$-28.66M
1W Performance:
+3.64%
1M Performance:
-6.50%
6M Performance:
-30.49%
1Y Performance:
-44.29%
1-Day Range:
$0.80
$0.8198
1-Week Range:
$0.7536
$0.8259
52-Week Range:
$0.7536
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Name
Hyperfine Inc
Sector
Industry
Phone
866-796-6767
Address
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.8133 | 86.25M | 15.33M | -34.78M | -28.66M | -0.4087 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-31-22 | Initiated | Evercore ISI | Outperform |
| Apr-14-22 | Initiated | Wells Fargo | Overweight |
Hyperfine Inc Stock (HYPR) Latest News
Hyperfine stock reports 45 percent revenue growth - AD HOC NEWS
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026Slideshow (NASDAQ:HYPR) 2026-06-05 - Seeking Alpha
BTIG reiterates Hyperfine stock rating on commercial progress By Investing.com - Investing.com Nigeria
HYPR Reiterated by BTIG -- Price Target Maintained at $2.00 - GuruFocus
BTIG reiterates Hyperfine stock rating on commercial progress - Investing.com
BTIG reiterates Buy rating on Hyperfine, $2 price target - tradingview.com
Hyperfine Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
Hyperfine stock holds steady as investors await fresh signals - AD HOC NEWS
Hyperfine completes enrolment in contrast-enhanced Swoop MRI Study - Indian Pharma Post
Hyperfine CEO Maria Sainz Wins 2026 MedtechWOMEN Leadership Award - citybiz
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award - Business Wire
Hyperfine completes enrollment in contrast MRI study By Investing.com - Investing.com Australia
Hyperfine completes enrollment in contrast MRI study - Investing.com
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents - Business Wire
Hyperfine stock maintains buy rating at BTIG on AI software update - Investing.com Canada
Lioness Medtech Showcasing Hyperfine Swoop at Röntgenveckan 2026 - marketscreener.com
HYPR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hyperfine (HYPR) Holds at $0.81, Pressing Against Support After Mild PullbackMarket Neutral Pair - siam.in
Hyperfine Forms Global Neurosurgery Advisory Council - Medical Product Outsourcing
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Yahoo Finance
Hyperfine reports 3,000 scans completed in first office year By Investing.com - Investing.com Nigeria
Hyperfine reports 3,000 scans completed in first office year - Investing.com
Hyperfine (HYPR) Earnings Update: The Available Earnings Metric Delivers a Beat at the Close; Market Response: Shares Finish 4.21% Down for the Current SessionEnergy Earnings Report - vinanet.vn
HYPR | Hyperfine, Inc. Class A FinancialsRevenue Breakdown - Quiver Quantitative
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
BTIG reiterates Hyperfine stock rating on FDA software clearance By Investing.com - Investing.com Canada
BTIG reiterates Hyperfine stock rating on FDA software clearance - Investing.com
Hyperfine Wins FDA Clearance for Next Optive AI Software - Medical Product Outsourcing
Hyperfine receives FDA clearance for Swoop MRI software update - Investing.com
Hyperfine receives FDA clearance for Swoop MRI software update By Investing.com - Investing.com South Africa
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings - Business Wire
Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Hyperfine Inc. (HYPR) Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Edge LowerEarnings Momentum Score - vinanet.vn
HYPR Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares SlipEarnings Stability Report - vinanet.vn
Hyperfine Inc. (HYPR) Edges Lower to $0.9 as Shares Trade Within Narrow RangeLiquidity Order Flow - vinanet.vn
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
HYPR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 2.83%EPS Surprise History - dars.gov.et
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine Inc Stock (HYPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):